December 22, 2015
FDA approves India’s Aurobindo’s generic version of Alcon’s Patanol
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% which makes the product is ready for launch.